Literature DB >> 6267269

The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog.

K L Magleby, B S Pallotta, D A Terrar.   

Abstract

1. The effect of tubocurarine on amplitudes of end-plate currents in response to trains of repetitive stimulation (50-150/sec) was investigated in voltage-clamped muscle fibres of the rat, mouse and frog. 2. In rat and mouse muscle, the presence of tubocurarine led to a more rapid decline (rundown) in the amplitudes of successive end-plate currents during trains of impulses. In frog, tubocurarine caused an increase in apparent facilitation of end-plate current amplitudes during the first few impulses of repetitive stimulation; this increase was followed by a more rapid rundown of end-plate current amplitude. 3. These effects of tubocurarine appear not to be an artifact resulting from inadequate control of membrane potential in voltage-clamped fibres. 4. The more rapid rundown during trains of end-plate currents in the presence of tubocurarine showed little variation with membrane potential indicating that voltage-sensitive channel blockade by tubocurarine was not a major factor contributing to the rundown. 5. The effect of tubocurarine on the apparent facilitation and rundown of end-plate current amplitudes was typically decreased by reducing the frequency of stimulation. 6. These results suggest that tubocurarine affects transmitter release at neuromuscular junctions during repetitive stimulation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6267269      PMCID: PMC1275543          DOI: 10.1113/jphysiol.1981.sp013618

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  39 in total

1.  THE EFFECT OF TUBOCURARINE ON ACETYLCHOLINE RELEASE FROM MOTOR NERVE TERMINALS.

Authors:  L BEANI; C BIANCHI; F LEDDA
Journal:  J Physiol       Date:  1964-11       Impact factor: 5.182

2.  The release of acetylcholine in the isolated rat diaphragm.

Authors:  K KRNJEVIC; J F MITCHELL
Journal:  J Physiol       Date:  1961-02       Impact factor: 5.182

3.  Does curare affect transmitter release?

Authors:  A Auerbach; W Betz
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

4.  Reduction of transmitter release by D-tubocurarine.

Authors:  J I Hubbard; D F Wilson; M Miyamoto
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

5.  Does d-tubocurarine inhibit the release of acetylcholine from motor nerve endings?

Authors:  C C Chang; H C Cheng; T F Chen
Journal:  Jpn J Physiol       Date:  1967-10-15

6.  Voltage jump analysis of procaine action at frog end-plate.

Authors:  P R Adams
Journal:  J Physiol       Date:  1977-06       Impact factor: 5.182

7.  Action potentials without contraction in frog skeletal muscle fibers with disrupted transverse tubules.

Authors:  P W Gage; R S Eisenberg
Journal:  Science       Date:  1967-12-29       Impact factor: 47.728

8.  The prejunctional actions of some non-depolarizing blocking drugs.

Authors:  L C Blaber
Journal:  Br J Pharmacol       Date:  1973-01       Impact factor: 8.739

9.  Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells.

Authors:  P Ascher; W A Large; H P Rang
Journal:  J Physiol       Date:  1979-10       Impact factor: 5.182

10.  The effect of curare on the release of acetylcholine from mammalian motor nerve terminals and an estimate of quantum content.

Authors:  P Fletcher; T Forrester
Journal:  J Physiol       Date:  1975-09       Impact factor: 5.182

View more
  22 in total

1.  Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14.

Authors:  Bula J Bhattacharyya; Scott M Wilson; Hosung Jung; Richard J Miller
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-09       Impact factor: 4.249

2.  The effects of muscarine and atropine reveal that inhibitory autoreceptors are present on frog motor nerve terminals but are not activated during transmission.

Authors:  M S Arenson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-02       Impact factor: 3.000

3.  Reversals of the neostigmine-induced tetanic fade and endplate potential run-down with respect to the autoregulation of transmitter release.

Authors:  C C Chang; S M Chen; S J Hong
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

4.  Phenthonium, a quaternary derivative of (-)-hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals.

Authors:  M L Fann; C Souccar; A J Lapa
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

5.  Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.

Authors:  S J Hong; C C Chang
Journal:  Br J Pharmacol       Date:  1991-04       Impact factor: 8.739

6.  Phorbol esters and adenosine affect the readily releasable neurotransmitter pool by different mechanisms at amphibian motor nerve endings.

Authors:  T J Searl; E M Silinsky
Journal:  J Physiol       Date:  2003-09-12       Impact factor: 5.182

7.  Nerve terminal currents induced by autoreception of acetylcholine release.

Authors:  W M Fu; H C Liou; Y H Chen
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Effects of (+)-tubocurarine on [3H]acetylcholine release from the rat phrenic nerve at different stimulation frequencies and train lengths.

Authors:  I Wessler; J Rasbach; B Scheuer; U Hillen; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

9.  Presynaptic actions of curare and atropine on quantal acetylcholine release at a central synapse of Aplysia.

Authors:  G Baux; L Tauc
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

10.  Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse.

Authors:  B Lang; J Newsom-Davis; C Prior; D Wray
Journal:  J Physiol       Date:  1983-11       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.